Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients

Author:

Marie SolèneORCID,Frost Kayla L.ORCID,Hau Raymond K.ORCID,Martinez-Guerrero Lucy,Izu Jailyn M.,Myers Cassandra M.ORCID,Wright Stephen H.,Cherrington Nathan J.

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference616 articles.

1. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases;Chalasani;Hepatology,2018

2. Nonalcoholic fatty liver disease review: diagnosis, treatment, and outcomes;Ahmed;Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc,2015

3. Changes in the prevalence of hepatitis C virus infection, non-alcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation;Goldberg;Gastroenterology,2017

4. Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States;Younossi;Clin Gastroenterol Hepatol,2021

5. Fibrosis progression in nonalcoholic fatty liver versus nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies;Singh;Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc,2015

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3